Asian Fund for Cancer Research Limited – AFCR shared a post on LinkedIn:
“How is AI changing the future of cancer care?
At BIOHK2026 Day Three, Prof. Raju Kucherlapati, Paul C. Cabot Professor of Genetics and Professor of Medicine at Harvard Medical School and Scientific Advisor to the Asian Fund for Cancer Research Limited (AFCR), explored the impact of AI on cancer precision medicine.
From predicting cancer risk and detecting disease earlier to helping guide more personalized treatment decisions, AI and genomics are strengthening the possibilities of precision medicine—giving researchers and clinicians a more detailed view of cancer and each patient’s disease.
Better data. Greater precision. Smarter decisions for patients.
Other posts about BIOHK2026 on OncoDaily.